Engaging with Physicians and Patients in a Changing WorldIn the constantly changing world of healthcare provision, two major themes have been emerging, both of which are interconnected:...
May You Live in Interesting TimesMay You Live in Interesting Times - a Curse or a Blessing? “May You Live in Interesting Times” – this old saying might suggest a blessing...
Healthcare in Crisis – What Can Pharma Do?Healthcare systems continue to struggle to cope with the demands of the ageing population along with advances in medicine that are...
Brexit – Breaking up is hard ….But building a new relationship will be harder ‘Brexodus’ has begun. Amsterdam has been chosen as the new location for the European...
Is Big Pharma Getting Smaller?Does Pfizer’s consumer healthcare announcement herald a trend towards slimmer, more focused business models? Pfizer’s announcement that...
New challenge for industry – governments want bigger role in price setting and R&DThe “financial toxicity” posed by very expensive cancer therapies was a major talking point at the recent American Society of Clinical...
‘Brexit’ – into the unknown“there is no plan” In the current political and economic turmoil after the ‘Leavers’ won victory in the UK referendum on whether Britain...
